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Abstract
Global climate change is predicted to lead to an increase in infectious disease outbreaks. Reliable surveillance for diseases
that are most likely to emerge is required, and given limited resources, policy decision makers need rational methods with
which to prioritise pathogen threats. Here expert opinion was collected to determine what criteria could be used to
prioritise diseases according to the likelihood of emergence in response to climate change and according to their impact.
We identified a total of 40 criteria that might be used for this purpose in the Canadian context. The opinion of 64 experts
from academic, government and independent backgrounds was collected to determine the importance of the criteria. A
weight was calculated for each criterion based on the expert opinion. The five that were considered most influential on
disease emergence or impact were: potential economic impact, severity of disease in the general human population, human
case fatality rate, the type of climate that the pathogen can tolerate and the current climatic conditions in Canada. There
was effective consensus about the influence of some criteria among participants, while for others there was considerable
variation. The specific climate criteria that were most likely to influence disease emergence were: an annual increase in
temperature, an increase in summer temperature, an increase in summer precipitation and to a lesser extent an increase in
winter temperature. These climate variables were considered to be most influential on vector-borne diseases and on food
and water-borne diseases. Opinion about the influence of climate on air-borne diseases and diseases spread by direct/
indirect contact were more variable. The impact of emerging diseases on the human population was deemed more
important than the impact on animal populations.
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Introduction
It has been predicted that ‘‘global warming’’ will cause
unprecedented changes to the earth’s climate [1]. North America
and the Arctic regions in particular, will experience warmer
temperatures, more rainfall, more frequent droughts, and extreme
weather events such as hurricanes and tornadoes [2–4]. These
events are likely to change the incidence and distribution of
emerging and re-emerging infectious diseases [1]. Climate could
affect, for example, the range and population size of pathogens,
hosts and vectors, the length of the transmission season, and the
timing and persistence of outbreaks. Increased temperatures and
altered rainfall patterns are expected to promote the geographic
occurrence and abundance of vector-borne and water-borne
diseases in particular [1]. Changes in climate might also hinder the
emergence of some diseases. Milder winters and hotter, humid
summers could favour West Nile virus and Lyme disease but
drought or heavy rainfall may keep them in control [5]. Finally,
the distribution of diseases may be indirectly affected, as the
impacts of climate change in some areas (desertification, flooding)
may lead to migration of human populations and changes in
human behaviour [3].
The impact of disease emergence in Canada could be
substantial. The economic effects of zoonoses in Canada range
from lost work productivity to international trade and travel
restrictions [6]. The economic cost of gastro-intestinal illness in
Canada, for example, has been estimated at $3.7 billion annually
[7].
In order to detect and respond to future disease agents emerging
as a result of climate change, reliable surveillance for diseases that
are most likely to be influenced by climate is required, with
particular attention to those with potentially large public health
impacts [8]. Policy decision makers therefore need to be able to
prioritise a list of potential emerging or re-emerging pathogens
that are likely to affect animal and human populations. We define
an emerging infectious disease as a disease that has newly
appeared in a population or that has existed but is rapidly
increasing in incidence or geographic range [9].
Rational priority setting requires understanding of a complex
system, since different criteria and priorities will affect the decision
to address a particular disease threat. In recent years progress has
been made in identifying the key characteristics of potential
emerging infectious diseases and attempts have been made to
prioritise infectious diseases in terms of their risk of emergence or
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impact in some countries (e.g.[10,11]). Here the focus is on
pathogen characteristics and the potential influence of climate
change in Canada.
The aim of this work was to identify criteria that might be used
to prioritise diseases and to use expert opinion to determine the
importance of these criteria. Expert opinion was collected via
electronic questionnaire. Collation of this expert opinion is
essential to subsequent work that will develop ranking methods
and multi-criterion decision approaches that can be used to
prioritise human and animal disease threats according to how
likely they are to emerge in Canada in response to climate change
and according to their impact.
Methods
Ethics statement
The study protocol including the written consent of all
participants, was approved by the University of Prince Edward
Island Research Ethics Board (REB Reference #6003938).
Study design summary
Identification of criteria and elicitation of expert opinion
followed the procedure outlined by [12], which draws on several
existing protocols. It involved the following steps:
N Questionnaire design, including identification of criteria that
might be used to prioritise diseases according to how likely
they are to emerge in Canada in response to climate change
and according to their impact.
N Recruitment of expert participants and distribution of
questionnaire.
N Calculation of criteria weighting based on expert opinion.
Identification of criteria and questionnaire design
A questionnaire was designed using Microsoft Word 2007 and
could be completed electronically. It presented a list of 40 criteria
that might be used to prioritise diseases according to how likely
they are to emerge in Canada in response to climate change and
according to their impact (Table 1). Criteria were identified from
published literature, discussion with experts from universities and
government agencies, and where possible, informed by previous
disease prioritisation work (e.g. [1,10,13–18]. Some criteria were
frequently used in other prioritisation studies (e.g. incidence,
severity, mortality), while others were included specifically for the
project focus (e.g. criteria related to climate change). A measure-
ment scale was developed for each criterion, although it was not
presented to participants in this questionnaire and will not be
presented here since the aim of this paper focuses on expert
opinion around the criteria.
To provide structural cohesion, criteria were divided into 5
groups:
Section A: Disease epidemiology (containing 12
criteria). This section focused on pathogen characteristics
(criteria A1–A3) and recent trends in disease incidence (A4–A7).
Criteria also consider pathogen endemicity and potential for
introduction to and transmission within Canada (A8–A12).
Section B: Ability to monitor, treat and control disease (5
criteria). Criteria relate to national and international surveil-
lance (B1), diagnosis (B2), preventability (B3) and treatability (B4–
5) in humans and domesticated animals.
Section C: Influence of climate (12 criteria). Criteria
consider whether the pathogen, host and vector (where applicable)
would be able to survive in the current climate in Canada (C1, C2,
C12). The remaining criteria (C3–C11) consider how changes in
temperature and precipitation (in summer and winter) might
promote or inhibit the emergence of a pathogen. While there are a
wide range of climatic factors that might influence pathogen
emergence, criteria focused on these two aspects for two reasons.
Firstly, the number of criteria needed to be manageable for
prioritisation purposes. Secondly these climate processes are well
documented compared to others and of significant concern [3].
Global average temperature could rise by 1.4–5.8uC between 1990
and 2100, although Canada is likely to experience greater rates of
warming than many other regions of the world [19]. Although
climate change may affect different regions of Canada in different
ways, details of specific geographic areas were not included at this
stage of the prioritisation. Certain types of disease are more likely
to be influenced by climate than others, therefore four broad
disease groups were identified based on mode of transmission and
Section C was repeated for each transmission mode. These criteria
will be referred to with a subscript: vector-borne (CV), food and
water-borne (CFW), airborne (CA) and direct/indirect contact (CD).
There were therefore a total of 45 criteria related to climate (12 for
vector-borne disease and 11 each for the other modes of
transmission. Criterion CV12 ‘presence of a suitable vector in
Canada’ was only relevant to vector borne disease).
Section D: Burden of disease (8 criteria). While the aim of
this work was not a formal risk assessment, sections D and E
considered likely impacts if a pathogen did emerge in Canada.
Section D included criteria about disease incidence, pathogenicity,
severity and fatality in the human population and in the
domesticated animal population. Domesticated animal population
was specified because estimation of burden in wildlife populations
was beyond the scope of this research.
Section E: Economic, environmental and social impact (3
criteria). This section included three criteria to capture
information about economic impact (E1 - including costs for
control and health care), environmental impact (E2 - including the
impact on the environment and biodiversity) and social impact (E3
- including the perception in the media and general population) of
disease emergence in Canada.
In sections A, B and C questions were posed in the form: ‘Is this
criterion likely to influence the probability of an infectious disease
emerging in Canada?’. Participants were asked to select one
answer from: ‘don’t know’, ‘not likely’, ‘quite likely’, ‘likely’, ‘very
likely’ or ‘extremely likely’. In sections D and E participants were
asked, ‘How important is this criterion for prioritising infectious
diseases in terms of their impact if they did emerge in Canada in
response to climate change?’. One answer could be selected from
the options: ‘don’t know’, ‘not important’, ‘quite important’,
‘important’, ‘very important’, and ‘extremely important’. Cross
boxes were provided for responses.
Experts were provided with the following example as guidance:
‘if you think that one or some pathogen taxonomic groups are
more likely to emerge in response to climate change than others
then you think that this criterion is likely to influence the
probability of a disease emerging in response to climate change.
Therefore cross one of the boxes labelled ‘quite likely’, ‘likely’,
‘very likely’ or ‘extremely likely’ as appropriate. If you think that
the pathogen taxonomic group does not influence whether a
disease will emerge in response to climate change then cross the
‘not likely’ box’. Selection of the ‘don’t know’ answer was at the
discretion of the expert, however it was made clear that the start of
the questionnaire that the aim was to collect opinion, not to assess
level of knowledge. Participants were invited to suggest other
criteria or to alter existing criteria and space for additional written
information was provided.
Infectious Disease Emergence Due to Climate Change
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At the end of the questionnaire two additional questions were
presented. Experts were asked to rank (in ascending order from 1
to 5) the following taxonomic groups: bacteria (including
rickettsia), viruses (including prions), protozoa, fungi and hel-
minths, according to how likely they are to be influenced by
climate (5 =most likely to be influenced by climate). The same
rank could be chosen more than once if required. Similarly
participants were asked to rank the following modes of transmis-
Table 1. List of criteria to prioritise diseases according to how likely they are to emerge in Canada in response to climate change
(groups A to C) and according to their impact (groups D and E).
A. DISEASE EPIDEMIOLOGY
A1. Pathogen taxonomic group (bacteria, virus, fungi, helminth, protozoa).
A2. Pathogen zoonotic potential (zoonotic or not zoonotic).
A3. Pathogen endemicity to Canada (exotic, introduced sporadically or endemic to Canada).
A4. Current incidence of human disease in Canada (average number of new cases in the last 5 years).
A5. Current incidence of animal disease in Canada (average number of new cases in the last 5 years).
A6. Trend of human disease incidence in Canada in the last 5 years (decreasing, stable or increasing).
A7. Trend of animal disease incidence in Canada in the last 5 years (decreasing, stable or increasing).
A8. Number of ways the pathogen may enter Canada (e.g. via imports, bird migration, human entry).
A9. Type of climate that the pathogen can tolerate (dry, tropical, temperate or continental).
A10. Geographic proximity of the pathogen to Canada.
A11. Mode of transmission (direct, indirect via environmental reservoir or vector-borne).
A12. Amount of information that is known about risk factors for introduction and transmission.
B. ABILITY TO MONITOR, TREAT AND CONTROL DISEASE
B1. Effectiveness of national and international surveillance.
B2. Ability to diagnose disease in Canada (availability and sensitivity of diagnostic tests).
B3. Ability to prevent disease in Canada (e.g. by vaccination or public health education).
B4. Ability to treat disease in humans in Canada (availability and effectiveness of treatment).
B5. Ability to treat disease in domesticated animals in Canada (availability and effectiveness of treatment).
C. INFLUENCE OF CLIMATE CHANGE
C1. Climatic conditions in Canada.
C2. Presence of definitive host species in Canada.
C3. Annual increase in temperature in Canada.
C4. An increase in summer temperature in Canada.
C5. An increase in winter temperature in Canada.
C6. A decrease in summer temperature in Canada.
C7. A decrease in winter temperature in Canada.
C8. An increase in summer precipitation in Canada.
C9. An increase in winter precipitation in Canada.
C10. A decrease in summer precipitation in Canada.
C11. A decrease in winter precipitation in Canada.
C12. Presence of a suitable vector in Canada.
D. BURDEN OF DISEASE
D1. Likely incidence of human disease in Canada
D2. Pathogenicity in the general human population (not pathogenic or frequently pathogenic).
D3. Severity of disease in the general human population (mild, moderate or severe).
D4. Human case fatality rate.
D5. Likely incidence of disease in domesticated animals.
D6. Pathogenicity in domesticated animals (not pathogenic or frequently pathogenic).
D7. Severity of disease in domesticated animals (mild, moderate or severe).
D8. Domesticated animal case fatality rate (including the need for culling).
E. ECONOMIC, ENVIRONMENTAL AND SOCIAL IMPACT
E1. Potential economic impact (e.g. cost to industry and for control, health care, travel restrictions).
E2. Potential environmental impact (e.g. impact on air, water, soil, landscape and biodiversity).
E3. Potential social impact (e.g. level of media coverage, level of anxiety of the general population).
doi:10.1371/journal.pone.0041590.t001
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sion: direct/indirect contact, air-borne, water-borne, food borne
and vector-borne. Broad disease groupings were proposed based
on [1] and were modified following discussions with experts during
a pre-test phase.
The questionnaire was pre-tested by individuals at the
University of Prince Edward Island (UPEI), the Public Health
Agency of Canada (PHAC) and Canadian Food Inspection
Agency before being distributed to all participants.
Recruitment of expert participants and distribution of
questionnaire
Experts in the areas of infectious disease epidemiology, in
particular emerging diseases and climate change, were identified
through literature and internet searching and via recommenda-
tions from other recruited participants as well as individuals at
PHAC, British Columbia Centres for Disease Control, Ontario
Ministry of Agriculture, Veterinary Laboratories Agency UK and
Aboriginal Environmental Health. Experts were defined as
individuals whose past or present field contains the subject under
study i.e. infectious disease epidemiology and/or climate change,
following [20]. Inclusion criteria followed recommendations by
[21], which include evidence of expertise, understanding of the
problem area, reputation, availability and willingness to partici-
pate.
Experts were invited to take part in the research via an email
that explained the aim, methods and use of study data. The
questionnaire was approved by UPEI’s Research Ethics Board and
the information included a page for written informed consent. The
aim was to include individuals from a variety of backgrounds,
including public and animal health, federal and provincial
agencies, universities and independent organisations. The majority
of participants were based in Canada.
The questionnaire, project summary and instructions were
emailed to participants who were asked to respond within 10 days.
Non-responders were reminded once after 2 to 3 weeks. A Delphi-
like approach was used to obtain feedback from the participants at
the end of the study [22]. This involved providing an anonymous
summary of group results to participants and inviting them to
review and revise their individual answers in light of the response
from the other experts if they wished.
Calculation of criteria weighting based on expert opinion
Expert responses were used to calculate a weight for each of the
criteria and therefore to determine a relative ranking of criteria.
The ‘likelihood’ score (sections A, B and C) and the ‘importance’
score (sections D and E) was converted to values of 0, 0.1, 0.3, 0.5,
0.7, 0.9 and a weight calculated as the mean score of all experts.
This linear scale was chosen following methods used by [10]. The
number of ‘don’t know’ responses per criteria was tabulated as an
indicator of the level of uncertainty. These responses were
excluded from the mean weight calculation. (Throughout ‘uncer-
tainty’ will be used to describe ‘don’t know’ responses, compared
to ‘variability’ which will be used to describe the range of expert
response).
Results
Expert response
Of the 121 experts invited to take part (Table 2) a total of 86
agreed to contribute to this work. Of the remainder, 22 individuals
did not reply to the email, while 13 declined due to lack of
expertise or time. Of the 86, 64 completed the questionnaire
(response rate of 74%). Most respondents (55) were based at
Canadian institutions, others resided in the USA (4), UK (3),
France (1) and Japan (1), although most had specific knowledge of
epidemiology in Canada.
Revision of Expert Responses
A total of 19 participants responded after being sent an
anonymous summary of group results. Of these, 15 participants
did not alter any responses, while four altered their responses to an
average of 7 criteria (out of 73). The majority of participants chose
not to respond during this phase.
Summary of expert opinion
The ten criteria that were considered to be most likely to
influence the probability of a pathogen emerging in response to
climate change, or the impact if the pathogen did emerge in
Canada, were topped by potential economic impact and severity
and fatality of disease in the general human population (Table 3).
In the following summary the overall rank of the criterion (of a
total of 73) is indicated in brackets.
Disease epidemiology. Most criteria relating to disease
epidemiology were deemed likely to influence the probability of
disease emergence, in particular the type of climate that the
pathogen can tolerate (4), the mode of transmission (9) and the
number of ways that the pathogen can enter Canada (19).
Ability to treat and prevent disease. Of the prevention
criteria, the effectiveness of national and international surveillance
(15) was considered most important when prioritising pathogen
emergence. The ability to diagnose (20) and prevent (24) disease
was more likely to influence disease emergence than the ability to
treat (41) disease in Canada.
Influence of climate change in Canada. The two criteria
that were most likely to influence a disease emerging in Canada
were current climatic conditions in Canada (6), and the presence
of a definitive host species in Canada (8). These criteria always
ranked the highest irrespective of type of disease within this group
Table 2. Affiliation of participants and response rates.
Affiliation Invited to contribute Completed questionnaire
Government 39 19
Provincial government 22 14
Academic 50 27
Academic and government 4 1
Independent 6 3
Total 121 64
doi:10.1371/journal.pone.0041590.t002
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(Table 4). The presence of a suitable vector also ranked very highly
for vector-borne diseases. Changes in climate that tended to be of
most concern were an annual increase in temperature, an increase
in summer precipitation and an increase in summer temperature.
Burden of disease. The severity of disease (2), human case
fatality rate (3) and likely incidence in the human population (5)
were of considerable importance. Criteria related to the impact on
the animal population were of less concern – animal case fatality
rate (17) was of most importance followed by likely incidence in
the domestic animal population (23) and severity of animal disease
(28).
Economic, social and environmental impact. All three
criteria in this group were considered ‘very important’ when
assessing the impact of an emerging disease. Overall the economic
impact (1) was of most concern, the social impact (12) and
environmental impact (13) were of less concern.
Ranking of pathogen taxonomic group and mode of
transmission
A total of 47 participants completed the questions related to
ranking. Bacteria were most likely to be influenced by climate
(ranking number 5 most often), viruses tended to rank 4 or 5, and
protozoa tended to rank 3 (Figure 1). There was more variation in
expert opinion about the ranking of fungi and helminths. In
particular, there did not appear to be consensus about the
influence of climate on helminths, since 13 participants assigned a
rank of 5 (most likely to be influenced by climate) – second only to
bacteria in this regard - while 11 participants assigned a rank of 1
(least likely to be influenced by climate).
Participants typically ranked vector-borne diseases as the most
likely to be influenced by climate (ranking of 5), water-borne
diseases ranked 4, food-borne and air-borne diseases ranked 3,
with direct/indirect contact diseases having the lowest rank
(Figure 2).
Variability of expert opinion
The opinion around some criteria reached a fair degree of
agreement. For example, participants generally agreed that trends
of animal disease incidence in Canada over the past five years and
the mode of transmission are ‘likely’ and ‘very likely’ to influence
the probability of an infectious disease emerging in Canada in
response to climate change respectively (Figure 3a and 3b).
Similarly an increase in summer temperature is ‘very likely’ to
influence vector-borne disease emergence and pathogenicity in
domesticated animals is an ‘important’ criterion for prioritising
infectious diseases in terms of their impact (Figure 3c and 3d
respectively).
In contrast, there appeared to be little agreement among
participants for other criteria. For example, responses were highly
variable around views on the influence of criteria such as pathogen
taxonomic group, pathogen zoonotic potential, an annual increase
in temperature on direct/indirect contact diseases, and an annual
increase in temperature on air-borne diseases (Figure 4a, b, c and
d respectively).
The response to a small number of questions could almost be
characterised as being ‘bimodal’, in that the two most highly
selected responses were ‘not likely’ and ‘likely’. These criteria
Table 3. Ten criteria deemed the most likely to influence
pathogen emergence or impact.
Criteria Weighting
E1 Potential economic impact 0.713
D3 Severity of disease in the general human population 0.710
D4 Human case fatality rate 0.710
A9 Type of climate that the pathogen can tolerate 0.707
D1 Likely incidence of human disease in Canada 0.697
C1 Climatic conditions in Canada 0.697
C12 Presence of a suitable vector in Canada 0.697
C2 Presence of definitive host species in Canada 0.683
A11 Mode of transmission 0.660
D2 Pathogenicity in the general human population 0.654
Criteria labelled A to C relate to emergence, criteria labelled D and E relate to
impact. The weight was calculated as the mean score of all participant
responses.
doi:10.1371/journal.pone.0041590.t003
Table 4. Mean weight for criterion describing the influence of climate on disease emergence in Canada.
Climate criteria Mean Weight
Vector-borne Food and water-borne Air-borne Direct/indirect contact
C1 Climatic conditions in Canada 0.697 0.558 0.497 0.432
C2 Presence of a definitive host species in Canada 0.683 0.563 0.526 0.518
C3 An annual increase in temperature in Canada 0.585 0.482 0.369 0.379
C4 An increase in summer temperature in Canada 0.572 0.500 0.369 0.378
C5 An increase in winter temperature in Canada 0.551 0.400 0.343 0.369
C6 A decrease in summer temperature in Canada 0.322 0.247 0.258 0.263
C7 A decrease in winter temperature in Canada 0.314 0.230 0.324 0.263
C8 An increase in summer precipitation in Canada 0.597 0.524 0.329 0.353
C9 An increase in winter precipitation in Canada 0.412 0.409 0.239 0.300
C10 A decrease in summer precipitation in Canada 0.464 0.373 0.304 0.296
C11 A decrease in winter precipitation in Canada 0.323 0.278 0.270 0.227
C12 Presence of a suitable vector in Canada 0.697 NA NA NA
The weight was calculated as the mean score of all participant responses for four different modes of pathogen transmission.
doi:10.1371/journal.pone.0041590.t004
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included current incidence of human disease in Canada, the
amount of information that is known about risk factors for
introduction and transmission, an increase in summer temperature
on air-borne diseases, and an increase in summer precipitation on
air-borne diseases (Figure 5a, b, c and d respectively).
There were a total of 12 criteria which at least 20% of
participants thought were not likely to influence the probability of
disease emergence. Of these, ‘not likely’ was the modal answer in 7
cases. All of these criteria related to the influence of climate
change. The criteria were: a decrease in summer temperature (all
modes of transmission) a decrease in winter temperature (all modes
of transmission) and a decrease in winter precipitation (all modes
of transmission), a decrease in summer precipitation (food &
water-borne, air-borne and direct/indirect contact), an increase in
winter precipitation (air-borne and direct/indirect contact), an
increase in winter temperature (air-borne) and an increase in
summer precipitation (air-borne and direct/indirect contact).
However for all of these criteria, there were always some
participants who indicated that this criterion was likely to influence
disease emergence. None of the participants suggested removing
any of the criteria.
Uncertainty in expert opinion
To summarise uncertainty the percentage of ‘don’t know’
responses out of the total responses to all criteria within a group
was calculated. The highest levels of uncertainty were associated
with the influence of climate change on air-borne and on direct/
indirect contact diseases. Group percentages were as follows
(numbers in brackets show the percentage, followed by the
minimum and the maximum number of ‘don’t know’ responses for
criteria in the group: [A] disease epidemiology (3.0, 0–5), [B]
Figure 1. Pathogen taxonomic group ranked by 47 experts according to likelihood of being influenced by climate. a: helminths, b:
bacteria, c: viruses, d: protozoa, e: fungi. A rank of 1 indicates least likely and a rank of 5 most likely to be influenced by climate.
doi:10.1371/journal.pone.0041590.g001
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ability to monitor, treat and control disease (0.8, 0–1), [CV]
influence of climate change on vector-borne disease (5.1, 0–8),
[CFW] food and water-borne disease (5.1, 1–5), [CA] air-borne
disease (19.8, 6–13), [CD] direct/indirect contact diseases (20.7, 5–
12), [D] burden of disease (1.7, 0–2) and [E] economic,
environmental and social impact (0.6, 0–1).
No more than 10% of experts selected ‘don’t know’ in response
to any of the criteria in sections A, B, D or E. In section C no more
than 10% selected ‘don’t know’ for food and water-borne diseases.
More than 10% of responses were ‘don’t know’ to two criteria
relating to vector-borne diseases (an increase in winter precipita-
tion and a decrease in winter precipitation). More than 10% of
responses were ‘don’t know’ for 9 (of 11) criteria for air-borne
disease and 10 (of 11) criteria for direct/indirect contact disease.
More than 20% of responses were ‘don’t know’ for only one
criterion (a decrease in winter precipitation for air-borne disease).
There were no criteria for which ‘don’t know’ was the modal
response.
Expert suggestions
Participants were invited to comment on any aspect of the
questionnaire as they felt appropriate. Some participants suggested
additional criteria as follows:
N Presence of reservoir species and intermediate host species.
N Species susceptibility (including vectors).
N Number of potential hosts that can carry the pathogen.
N Likely incidence of disease in wild animals.
N Pathogen infectivity (ease of spread).
N Frequency of contacts with the pathogen (e.g. air travel routes,
importation of goods).
Figure 2. Disease mode of transmission ranked by 45 experts according to likelihood of being influenced by climate. a: vector-borne,
b: water-borne; c: food-borne; d: air-borne; e: direct/indirect contact transmission. A rank of 1 indicates least likely and a rank of 5 most likely to be
influenced by climate. A score of 0 indicated the opinion that climate does not have an influence on diseases with this mode of transmission.
doi:10.1371/journal.pone.0041590.g002
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N Probability of an outbreak in humans and probability of an
outbreak in animals.
N Notifiable status of the disease in Canada at the provincial,
territorial or federal levels.
N Impact on animal welfare, public health, international trade
and wider society (which includes environment and media).
N Potential impact on food security of First Nations, Inuit and
Metis people.
N Potential impact on development of diagnostic techniques for
northern diseases.
N Ability of the pathogen to survive in environmental media
outside of the host (e.g. water, soil).
N Other climatic factors: the number of frost free days, humidity
(in particular for air-borne diseases), prevailing wind conditions
and climatic patterns over time e.g. rainfall patterns.
In addition, some participants suggested criteria that tended to
relate to the indirect effects of climate change. Suggestions
included: potential socioeconomic and demographic changes in
populations, population density, overcrowding, heat stress, flood
risk, hygiene, living conditions, and increased use of air
conditioning units (as a result of increased temperature).
More general comments noted the complexity and uncertainty
associated with prioritisation and highlighted that although
climate change will have an effect, the system is very complex
and that impacts are difficult to predict. Finally participants
suggested focusing on particular issues, for example the speciality
of the user (e.g. public health, veterinarian), a specific geographic
region of Canada, or a specific disease group.
Discussion
Expert response rate and revision of responses
In order to design a reliable method of disease prioritisation,
criteria need to be explicit and should minimise the influence of
factors such as personal interest and political agenda [17]. This
work therefore invited input from a number of experts in order to
account for a range of opinions and to follow recommendations
that criteria should be open to criticism and revision (e.g.
[17,23,24]). Other disease prioritisation work has rarely used such
a large panel of experts (for a review see [23]). A large group has
the advantage of providing a substantial sample size, although may
be a disadvantage if those individuals have varying agendas and
are unable to reach consensus. Conversely, a small number of
experts are more likely to provide a biased set of answers reflecting
the perspectives of, for example, one particular sector or country of
origin [25]. Attempts were made to mitigate such bias by including
individuals from a range of backgrounds and by inviting
participants to revise their answers as an aid to reaching consensus.
Although the response rate to the summary of group results only
reached 30%, this is comparable to other studies that have assessed
disease risks using a Delphi approach, either remotely via email or
post [26,27], or face to face at a conference [28]. Lack of response
has been attributed to the repetitive and time consuming nature of
the procedure. In this study a Delphi approach would more
Figure 3. Opinion of 64 experts about the likelihood that ‘a criterion’ will influence infectious disease emergence - examples in
which participants’ opinions were generally in agreement. Criteria (number and description): a: A7 trend of animal disease incidence in
Canada in the last five years; b: A11 mode of pathogen transmission; c: CV4 an increase in summer temperature in Canada; d: D6 pathogenicity in
domesticated animals.
doi:10.1371/journal.pone.0041590.g003
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appropriately have involved a group meeting, however this was
not possible due to limited resources and the wide geographic
spread of the participants. It is important to note however, that
group meetings also have limitations; in particular they must avoid
the group being dominated by shared knowledge or over-strong
opinions and particularly the tendency of the group towards
overconfidence [21]. It is for these reasons that other expert
elicitation studies, for example, to assess food-borne disease in
Canada [29] or to evaluate control strategies of contagious animals
diseases [26,30] have preferred to elicit opinion via written
questionnaire to prevent any interaction or exchange of informa-
tion between participants.
The response rate did not vary according to sector and
participants tended to decline due to lack of time. Expert input was
not weighted according to sector because the background
information available (e.g. professional affiliation, geographic
location) was not considered to be a reliable way to assess bias.
Academic researchers based at universities, for example, are often
involved in government advisory roles and could not be classed as
purely ‘academic’. One study which did weight experts according
to their level of expertise in relation to specific pathogens found
that this had little effect on the overall conclusions [31]. The
authors would recommend collecting information about expert
affiliation during the elicitation phase.
This work assessed a relatively large number of criteria
compared to other disease prioritisation work
[10,11,14,15,17,18,32], (the maximum found in the literature
was forty [11]). The most recent prioritisation in Canada
established priorities for national communicable disease surveil-
lance in 1998 using only ten criteria [17]. In general these
prioritisation exercises dealt with disease emergence and did not
specifically consider climate change.
Criteria ranking
Criteria were ranked according to a mean score from the expert
opinion as a way to highlight those of most concern. The rank of a
criteria is likely to depend on the method of scoring and on the
measure used to rank (e.g. mean score) and therefore future work
to build a prioritisation tool will consider alternative methods of
ranking. Sensitivity analysis was conducted here in order to assess
the influence of uncertainty i.e. a ‘don’t know’ score on the
ranking. When the rank was recalculated as the mean score
including values of 0, there was little influence on overall ranking.
The top 15 criteria remained in the top 15 (only three criteria
changed rank) and of the lowest 15 ranked criteria, only 2 were
different to the original ranking method. This is primarily a
reflection of the limited proportion of ‘don’t know’ responses
overall, as well as their relatively homogeneous spread across
criteria.
Summary of expert opinion
The majority (six) of the ten most highly ranked criteria were
related to potential impacts of any emerging infectious disease on
the human population. After the economic impact, the severity,
fatality and likely incidence in the human population were of most
concern.
Disease epidemiology. Experts agreed that disease epide-
miology (in particular the mode of transmission and the type of
climate that the pathogen can tolerate) is likely to influence disease
emergence. Taxonomic group and zoonotic potential were both
‘very likely’ to influence disease emergence, although there was
Figure 4. Opinion of 64 experts about the likelihood that ‘a criterion’ will influence infectious disease emergence - examples in
which participants’ opinions were highly variable. Criteria (number and description): a: A1 pathogen taxonomic group; b: A2 pathogen
zoonotic potential; c: CD3 an annual increase in temperature in Canada; d: CA3 an annual increase in temperature in Canada.
doi:10.1371/journal.pone.0041590.g004
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considerable variation between experts despite evidence that the
majority of emerging disease events are zoonotic and are caused
by bacteria including rickettsia [16,33,34]. Methods of pathogen
entry were also likely to influence pathogen emergence and a
number of high risk methods of pathogen introduction have been
identified e.g. via human immigration, import of animal or animal
products [35] and via wild bird migration [36,37].
Ability to monitor, treat and control disease. Effective
surveillance was highlighted as a priority for infectious disease
control (rather than diagnosis, prevention or treatment measures)
as it has been in other studies [38]. The other measures are more
likely to be employed once the pathogen has emerged.
Influence of climate. The climate criteria that ranked most
highly (type of climate that the pathogen can tolerate and the
current climatic conditions in Canada (in relation to vector-borne
diseases) indicate that experts were most concerned about whether
the current climate would support pathogen survival and
transmission. Participants’ overall responses were in agreement
with the current literature which indicates that vector-borne
diseases are most likely to be influenced by the direct effects of
climate change, followed by food and water-borne diseases [1].
This is unsurprising because diseases that are most likely to
respond to climate change are those where the pathogen spends
some time in the environment. Annual and seasonal increases in
temperature and an increase in summer precipitation were
deemed most influential. Indeed, it is well known that increasing
temperature and precipitation tends to promote disease incidence
because the period of time required for pathogen replication
decreases and because blood-feeding arthropods often increase
their biting frequency and replication rates [39]. Similarly, the risk
of enteric disease is likely to increase with increasing temperature
and precipitation [5,40,41]. Water-borne outbreaks in Canada
have been associated with heavy precipitation, snowmelt and
flooding [42,43]. Higher temperatures in the Canadian Arctic
have implications for traditional lifestyles, wild food availability
and food storage, and may therefore result in an increase in food-
borne diseases such as gastroenteritis and botulism [8].
Participants were less concerned and also less certain about the
influence of climate on air-borne and direct/indirect contact
pathogens. Evidence for the influence of climate compared to
other modes of transmission may not be as abundant; however
climate does have known effects. A warmer and wetter winter may
reduce the occurrence of communicable diseases such as influenza,
while warm, dry summers and heavy precipitation in winter
provide optimal conditions for transmission of fungal spores that
cause, for example, Coccidioides immitis [1]. Participants appeared to
reflect this understanding, by judging that annual and seasonal
increases in temperature and increases in summer precipitation
would be most influential. However, participants did not appear to
agree that a decrease in summer precipitation would be more
influential than an increase in summer precipitation on air-borne
transmission.
Burden of disease. The burden of disease was a high
priority, with all four criteria relating to human disease featuring in
the top 10. In comparison the burden in the animal population
was of considerably less concern. At least two experts commented
that policymakers will always prioritise human health while animal
Figure 5. Opinion of 64 experts about the likelihood that ‘a criterion’ will influence infectious disease emergence - examples in
which participants’ opinions were apparently contradictory. Criteria (number and description): a: A4 current incidence of human disease in
Canada; b: A12 amount of information that is known about risk factors for introduction and transmission; c: CA4 an increase in summer temperature
in Canada; d: CA8 an increase in summer precipitation in Canada.
doi:10.1371/journal.pone.0041590.g005
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health concerns will be secondary and will typically be measured
in terms of loss of trade.
Economic, environmental and social impact. The expert
opinion supports other work that has stressed the need to consider
economic, social and environmental impact either within the same
prioritisation or separately [44], since impact of emergence can
have considerable and long-lasting consequences (e.g. [45,46]).
Expert suggestions
Participants suggested additional criteria for prioritisation
purposes. Many were already addressed in almost equivalent
terms within the questionnaire. For example, suggestions of
‘probability of an outbreak’ or ‘frequency of contacts with the
pathogen’ were addressed with criteria such as ‘number of ways
that the pathogen can enter Canada’ and ‘likely incidence of
disease in humans or animals’. One suggestion, which was not
covered in this assessment, and might be considered in future, was
the role of wildlife in pathogen emergence. There were a number
of suggestions for additional criteria relating to disease impact,
however as the purpose of this work was not a full risk assessment
only a few ‘general’ impact criteria were included.
Additional climate criteria suggestions (the influence of wind or
extreme events such as floods or droughts, and changes in climate
over time), while undoubtedly influential, might prove difficult to
estimate for many diseases in the Canadian context, particularly in
a timely and reliable manner as required for the tools that will be
developed from this work. Other suggestions relating to the
indirect influence of climate on disease were also excluded due to
the uncertainty and complexity of the subject [6]. One participant
summed up this perspective: ‘‘changes in vector biology may or
may not be overridden by changes in global movement patterns of
humans which may or may not be impacted by human
encroachment on wildlife, which may or may not be affected by
improvements in living conditions of some people in some places
as a result of predicted climate change’’.
The criteria used here were relatively simple. However, the
ultimate aim of this research is to design a practical method of
disease prioritisation which can identify pathogens that are likely
to be influenced by climate compared to those that are unlikely to
be influenced by climate. The criteria focused on the direct
influence of climate on the pathogen rather than on the disease
and asked separate questions about the availability of the host and
vectors, rather than assessing factors related to the pathogen,
disease and host in a single question. This is an important point,
since the influence of climate on the pathogen may be different to
its influence on the disease. For example, an increase in dry
climate in western Canada could result in a decline in cattle, other
livestock or some wildlife species, and therefore the emergence of a
disease could be impacted, although the effect on the pathogen
might be negligible.
The importance of qualitative assessment (such as this) in
developing strategies to adapt to climate change has been stressed
in a number of studies [31,47]. One recent assessment, for
example, of the impact of climate change on vector-borne viruses
in the European Union through the elicitation of expert opinion
also focused on temperature and precipitation after noting that
quantitative information is limited [31]. Although quantitative
studies on the burden of disease attributable to climate change are
currently scarce [48], measurement of disease burden using
Disability Adjusted Life Years (DALYs) have been developed [49].
While this requires assessment in different populations and
different ecological regions, incorporation of such measures in
prioritisation models would be advantageous where possible.
Variability
There were some criteria where expert opinion varied
considerably. It is likely that this was the result of disagreement
between experts. It is also possible that some criterion were not
specific enough, or had relevance only to certain pathogens. It is
unlikely to be due to lack of knowledge or uncertainty since in
these cases experts would have chosen to answer ‘don’t know’. The
low response rate to the summary of group results was
disappointing and it is possible that a higher response rate may
have resolved some of the variation in opinion. However, it is
worth noting that only 4 out of 19 experts chose to alter their
opinion and that a greater response rate might not necessarily
result in agreement. While lack of consensus does raise questions
as to whether such criteria should be included, it is reasonable to
include them (perhaps with a lower weighting) because at least
some experts deemed them influential. The variation in response
does not necessarily need to be considered as of concern. Diversity
of expert views itself carries valuable information [12], and the
variation in response can be accounted for in a practical manner
when designing a decision support tool.
The variation in response is unlikely due to difference in
interpretation of the ‘likelihood’ and ‘importance’ qualitative
scoring system even though experts were not provided with a
definition for each description. This is for a number of reasons.
Phrases were ordered on a five-tiered Likert scale according to
their meaning and no description or numerical values were
attached. Experts therefore chose an option relative to the other
options on the scale. Other studies have used a similar method of
qualitative scoring that have allowed consistent expert interpreta-
tion, e.g. a likelihood scale [50], a low to high scale [31], or a scale
from 1 to 10 [51]. None of the participants in the pilot study nor
the experts requested definitions for the likelihood and importance
scale.
A qualitative scale was deemed most appropriate for this study,
based on the fact that individuals prefer to use imprecise methods
such as verbal description of uncertainty when applied to events in
which the nature of the underlying uncertainty is also vague
compared to numerical responses when representing aleatory
uncertainty (chance or probability) [52]. Furthermore, qualitative
approaches tend to take less time than a quantitative approach.
Uncertainty
There appeared to be uncertainty about some of the criteria,
which was reflected by the number of experts who responded with
‘don’t know’. The greatest amount of uncertainty related to the
influence of climate on air-borne and direct/indirect contact
diseases. It is likely that this is due to limited availability of
information about predictable changes in climate, the influence of
climate on pathogens as discussed above or lack of reliable
information about the likely drivers of pathogen emergence in the
Canadian context, in particular for diseases that are currently
exotic. Uncertainty may also result from the level of expertise of
individual participants. Although some work has shown that
uncertainty was not necessarily due to the self-attributed level of
expertise [29], in hindsight it may have been useful to ask experts
to indicate their level of certainty about each criterion during the
elicitation process. This was not done because it was considered to
be too time consuming and would likely reduce the response rate.
It is also important to note that it is doubtful whether an expert’s
own subjective judgement of their ‘level of certainty’ provides a
good estimate of the value of the information or whether it
introduces more bias [53]. In this study a number of individuals
declined to participate due to a self-assessed lack of expert
knowledge and it is therefore possible that individuals were
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included, to some extent, who were confident in their own
experience level (as in [54]).
Conclusion
Although our study cannot account for the complexity that
underlies disease dynamics, it can provide a basis for early warning
and identification of potential pathogen threats. Collation of
expert opinion provides the foundation for a broad, generic tool
for disease prioritisation. Future work will develop ranking
methods and multi-criteria decision analysis tools that consider
the complex nature of disease prioritisation and that are necessary
for a consistent and structured method for prioritising emerging
(or re-emerging) infectious diseases associated with climate change.
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